Repare Therapeutics (RPTX) Stock Forecast & Price Target

$3.29

-0.03 (-0.90%)

(As of 09/17/2024 ET)

Repare Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 5 Analyst Ratings

Based on 5 Wall Street analysts who have issued ratings for Repare Therapeutics in the last 12 months, the stock has a consensus rating of "Buy." Out of the 5 analysts, 4 have given a buy rating, and 1 has given a strong buy rating for RPTX.

Consensus Price Target

$17.33
426.85% Upside

High Forecast	$25.00
Average Forecast	$17.33
Low Forecast	$10.00

According to the 5 analysts' twelve-month price targets for Repare Therapeutics, the average price target is $17.33. The highest price target for RPTX is $25.00, while the lowest price target for RPTX is $10.00. The average price target represents a forecasted upside of 426.85% from the current price of $3.29.

Type	Current Forecast 9/19/23 to 9/18/24	1 Month Ago 8/20/23 to 8/19/24	3 Months Ago 6/21/23 to 6/20/24	1 Year Ago 9/19/22 to 9/19/23
Consensus Rating	Buy	Buy	Buy	Moderate Buy
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$17.33	$17.33	$17.33	$20.75
Forecasted Upside	426.85% Upside	147.50% Upside	147.50% Upside	78.30% Upside

Get Repare Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter.

Introducing the Perceptron (Ad)

On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.

Just click here to register.

RPTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

RPTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Repare Therapeutics Stock vs. The Competition

Type	Repare Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	3.20	2.77	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	426.85% Upside	1,007.12% Upside	7.65% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/4/2024	HC Wainwright 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$10.00 ➝ $10.00	+255.87%
7/29/2024	Lifesci Capital 2 of 5 stars	C. Zhu Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
4/19/2024	Bloom Burton 4 of 5 stars	D. Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Accumulate ➝ Buy
10/16/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$30.00 ➝ $25.00	+372.59%
9/25/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$16.00 ➝ $17.00	+39.46%
2/27/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight	$15.00 ➝ $14.00	+32.70%
1/6/2023	Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Chiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight	$28.00	+92.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 08:12 AM ET.

RPTX Forecast - Frequently Asked Questions

What is Repare Therapeutics' forecast for 2024?: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Repare Therapeutics is $17.33, with a high forecast of $25.00 and a low forecast of $10.00.
Should I buy or sell Repare Therapeutics stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Repare Therapeutics in the last twelve months. There are currently 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RPTX shares.
Does Repare Therapeutics's stock price have much upside?: According to analysts, Repare Therapeutics's stock has a predicted upside of 156.28% based on their 12-month stock forecasts.
Has Repare Therapeutics been upgraded by Wall Street analysts recently?: Over the previous 90 days, Repare Therapeutics's stock had 1 upgrade by analysts.
What analysts cover Repare Therapeutics?: Repare Therapeutics has been rated by research analysts at HC Wainwright, and Lifesci Capital in the past 90 days.
Do Wall Street analysts like Repare Therapeutics more than its competitors?: Analysts like Repare Therapeutics more than other "medical" companies. The consensus rating for Repare Therapeutics is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how RPTX compares to other companies.